Equifax (EFX) Could Be 35% Undervalued Following New Fraud Tool Launches
Why Equifax’s New Fraud Tools Matter For Investors
Equifax (EFX) has rolled out two new fraud intelligence products, Signal Score for Email and Signal Score for Device, aimed at digital commerce, banking and telecom customers facing more complex online attacks.
These tools use Equifax first party data to assess whether an email or device involved in a transaction looks trustworthy. The goal is to reduce automated fraud while keeping checkouts and account openings relatively quick for legitimate users.
Against this product news backdrop, Equifax’s share price has retreated, with a 30 day share price return down 24.5% and year to date share price return down 34.6%, while the 1 year total shareholder return has declined 40.2%. This suggests that sentiment around future risk and reward has cooled despite recent product launches in fraud prevention and healthcare screening.
Scan how Equifax’s fraud push compares with peers by reviewing a curated group of data driven businesses in the 19 high quality undiscovered gems.
Bulls see Equifax’s fraud and healthcare launches as mispriced after a steep share pullback. Bears focus on sentiment and execution risk. Which story does the valuation actually reflect?
Most Popular Narrative: 35% Undervalued
Equifax closed at $140.00 while the most followed narrative pegs fair value at $214.95, so the gap between price and modeled upside is wide and built on a very specific earnings power story.
Global cloud migration and proprietary AI platforms are now being used to double Equifax’s AI related productivity target to US$150m of run rate savings for 2026 to 2028. This directly supports EBITDA margin expansion above the 50 basis point long term leverage framework and adds to earnings capacity.
See why 31 investors see Equifax as 35% undervalued.
Result: Fair Value of $214.95 (UNDERVALUED)
Still, the Equifax story depends on government verification recovering from recent declines, and on legal and regulatory costs not eroding that earnings power narrative.
Find out about the key risks to this Equifax narrative.
Next Steps
With sentiment divided between sharp price declines and a compelling fair value story, put the data in front of you quickly and form your own judgement using the 4 key rewards and 1 important warning sign
Ready For More Equifax Sized Ideas?
If you stop with Equifax, you risk missing out on other opportunities that might fit your style even better, so widen the lens using these focused screens.
- Spot potential comeback candidates early by scanning the 9 elite penny stocks with strong financials before attention and pricing catch up.
- Zero in on quality at a marked down tag with the 31 high quality undervalued stocks while prices still reflect cautious expectations.
- Build a steadier core around durable balance sheets using the list of solid balance sheet and fundamentals (26 results) before those strengths become crowded trades.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com